Towards clinical evidence in particle therapy: ENLIGHT, PARTNER, ULICE and beyond
نویسندگان
چکیده
Department of Radiation Oncology, University Hospital of Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany CERN, CH-1211, Geneva 23, Switzerland AKHWien, Währinger Gürtel 18–20, A-1090 Vienna, Austria Istituto Europeo di Oncologia, via Ripamonti 435, Milano, Italy Heidelberger Ionenstrahl Therapiezentrum (HIT), Im Neuenheimer Feld 450, 69120 Heidelberg, Germany Gesellschaft für Schwerionenforschung (GSI), Biophysik, Darmstadt, Germany CNAO, Pavia, Italy Ludwigs-Maximilians-Universität Munich, Physical Faculty, Munich, Germany GCS-ETOILE, 60 avenue Rockefeller, 69008 Lyon, France CERN, CH-1211, Geneva 23, Switzerland Department of Radiation Oncology and OncoRay Center, University Hospital, Carl Gustav Carus Dresden and HelmholtzCenter Dresden-Rossendorf, Fetscherstrasse 74, 01307 Dresden, Germany *Corresponding author: Department of Radiation Oncology, University Hospital of Heidelberg, ImNeuenheimer Feld 400, 69120 Heidelberg, Germany. Tel: +49-6221-56-8202; Fax: +49-6221-56-5353; Email: [email protected]
منابع مشابه
Medical Applications at CERN and the ENLIGHT Network
State-of-the-art techniques derived from particle accelerators, detectors, and physics computing are routinely used in clinical practice and medical research centers: from imaging technologies to dedicated accelerators for cancer therapy and nuclear medicine, simulations, and data analytics. Principles of particle physics themselves are the foundation of a cutting edge radiotherapy technique fo...
متن کاملIntroduction to the EC's Marie Curie Initial Training Network (MC-ITN) project: Particle Training Network for European Radiotherapy (PARTNER)
PARTNER (Particle Training Network for European Radiotherapy) is a project funded by the European Commission's Marie Curie-ITN funding scheme through the ENLIGHT Platform for 5.6 million Euro. PARTNER has brought together academic institutes, research centres and leading European companies, focusing in particular on a specialized radiotherapy (RT) called hadron therapy (HT), interchangeably ref...
متن کاملEvidence-Informed Deliberative Processes for Universal Health Coverage: Broadening the Scope; Comment on “Priority Setting for Universal Health Coverage: We Need Evidence-Informed Deliberative Processes, Not Just More Evidence on Cost-Effectiveness”
Universal health coverage (UHC) is high on the global health agenda, and priority setting is fundamental to the fair and efficient pursuit of this goal. In a recent editorial, Rob Baltussen and colleagues point to the need to go beyond evidence on cost-effectiveness and call for evidence-informed deliberative processes when setting priorities for UHC. Such processes are crucial at every step on...
متن کاملCarbon ion therapy to debut in Europe.
fter 14 years of construction, the Large Hadron Collider, the world’s largest particle accelerator, fired its first beam of protons in September from its home at the European Organization for Nuclear Research (CERN) near Geneva. Now a spinoff technology for treating cancer is also nearing its European debut. The first European center to offer carbon ion therapy — a type of radiation treatment t...
متن کاملConnection of European particle therapy centers and generation of a common particle database system within the European ULICE-framework
BACKGROUND To establish a common database on particle therapy for the evaluation of clinical studies integrating a large variety of voluminous datasets, different documentation styles, and various information systems, especially in the field of radiation oncology. METHODS We developed a web-based documentation system for transnational and multicenter clinical studies in particle therapy. 560 ...
متن کامل